Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 33 - Antiparasitic agents
Patents for A61P 33 - Antiparasitic agents (21,787)
12/2003
12/18/2003WO2003037164A3 Methods and compositions for the diagnosis and treatment of hematological disorders using 2777
12/18/2003WO2003029437A3 Secreted proteins
12/18/2003WO2003015773A3 2-amino-4,5-trisubstituted thiazolyl derivatives and their use against autoimmune diseases
12/18/2003WO2003000864A8 Nucleic acid-associated proteins
12/18/2003WO2002058723A3 Chemokines as adjuvants of immune response
12/18/2003US20030232813 Novel amino substituted pyrimidinone derivatives
12/18/2003US20030232750 Indolicidin peptide analogues containing at least two basic amino acids; bactericide
12/18/2003US20030232349 Nucleic acid and amino acid sequences of proteases and the use of these sequences in the diagnosis and treatment of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, and neurological disorders
12/18/2003CA2488801A1 Ether substituted imidazopyridines
12/18/2003CA2488567A1 (halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents
12/18/2003CA2488402A1 Pyrazole-derivatives as p38 kinase inhibitors
12/18/2003CA2488108A1 Liquid formulation of decitabine and use of the same
12/18/2003CA2487838A1 Methods and compounds for inhibiting the cytokine or biological activity of mif
12/17/2003EP1371370A1 Drugs containing reduced vitamin b2
12/17/2003EP1370659A2 Proteins, polynucleotides encoding them and methods of using the same
12/17/2003EP1370586A2 Nuclear hormone receptor ligand binding domain
12/17/2003EP1370584A2 Nuclear hormone receptor ligand binding domain
12/17/2003EP1370566A1 Synthetic derivatives of 21-butenyl and related spinosyns
12/17/2003EP1370255A2 Cdc25 phosphatase inhibitors
12/17/2003EP1147121B1 Ketolide antibiotics
12/16/2003US6664397 Administering to subject effective dose of (+)-mefloquine or pharmaceutically acceptable salt thereof substantially free of (-)-enantiomer; reduced side effects
12/16/2003US6664264 Thioether substituted imidazoquinolines
12/16/2003US6664237 Oral treatment of companion animals with ectoparasiticidal spinosyns
12/16/2003US6664230 Orally administered peptides to ameliorate atherosclerosis
12/16/2003US6664090 Carboxylesterase nucleic acid molecules, proteins and uses thereof
12/16/2003US6664040 Complexing to polypeptides; antiproliferation agent
12/16/2003US6663876 Methods and compositions for treating ectoparasite infestation
12/16/2003US6663871 Non-replicating or replication- impaired pox virus vector carrying at least one CD8 T cell epitope which is also present in the priming composition, malaria
12/16/2003CA2259297C Parenteral paclitaxel in a stable non-toxic formulation
12/11/2003WO2003102207A2 Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments
12/11/2003WO2003101996A2 Esters in position 20 of camptothecins
12/11/2003WO2003101995A2 Camptothecins with a modified lactone ring
12/11/2003WO2003101984A1 Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same
12/11/2003WO2003101979A1 Anthelmintic and insecticidal thiophene derivatives
12/11/2003WO2003101477A1 Use of uk114 in the treatment of leishmaniasis
12/11/2003WO2003101450A1 N- ((3-oxo2, 3-dihydro-1h-isoindol-1-yl) acetyl) guanidine derivatives as nhe-1 inhibitors for the treatment of infarction and angina pectoris
12/11/2003WO2003051289A3 Solubilized topoisomerase poison agents
12/11/2003WO2003022883A3 Use of proteins for the production of a medicament for stimulating the innate non specific immune system
12/11/2003WO2002092552A3 Benzamidoacetonitriles and their use as antiparasitics
12/11/2003US20030229109 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
12/11/2003US20030229047 Liquid formulation of decitabine and use of the same
12/11/2003US20030229032 Parasiticides, nematocides
12/11/2003US20030229031 13-Methyl erythromycin derivatives
12/11/2003US20030228625 Method for diagnosing and monitoring hemostatic dysfunction, severe infection and systematic inflammatory response syndrome
12/11/2003US20030228576 Nucleotide sequence coding for a cleaving enzyme; can use in conjuction with substrate to produce toxins which impair abnormal cell growth; antitumor agents
12/11/2003US20030228357 Sizing, compaction, forming tablets
12/11/2003CA2706635A1 Camptothecins with a modified lactone ring
12/11/2003CA2487666A1 Anthelmintic and insecticidal thiophene derivatives
12/10/2003EP1368473A2 Neurotransmission-associated proteins
12/10/2003EP1368458A2 Interferon-alpha induced gene
12/10/2003EP1368457A1 Use of gram-negative bacterial membrane fraction for inducing the maturation of dendritic cells
12/10/2003EP1368321A1 Anti-malarial compounds
12/10/2003EP1368314A1 N-4-piperidinyl compounds as ccr5 modulators
12/10/2003EP1368054A2 Using neural thread proteins to treat tumors and other hyperproliferative disorders
12/10/2003EP1368040A2 Use of 5-substituted nucleosides and/or prodrugs thereof in the resistance-free treatment of infectious diseases
12/10/2003EP1367995A1 Compositions and methods for enhancing drug delivery across and into epithelial tissues
12/10/2003EP1367891A1 Pharmaceutical composition containing aminoacetonitrile compounds and the use thereof for the preparation of a pharmaceutical composition for the treatment of endoparasitic pests in animals
12/10/2003EP1177191B1 Substituted benzimidazole, the production thereof and the use thereof as means against parasitic protozoa
12/10/2003EP0680316B1 Novel parasitic helminth proteins
12/10/2003CN1461310A ANtibodies that bind human interleukin-18 and methods of making and using
12/10/2003CN1461213A 1-amino-alkylcyclohexanes as trypanocidal agents
12/10/2003CN1460485A New process for making animal medicine madumycin ammonium, ivermection or dikezhuli premixed agent
12/10/2003CN1130359C Substituted benzimidazole, its preparation and use as means against parastic protozoa
12/10/2003CN1130345C Amino quinoline derivatives
12/09/2003US6660840 Ability to stimulate a Th1 response in peripheral blood mononuclear cells; contain a biologically active portion of a Leishmania braziliensis
12/09/2003US6660768 Parasiticidal compositions and methods of use
12/09/2003US6660744 Pyrazolopyrimidines as therapeutic agents
12/09/2003US6660723 Activating primate gamma delta lymphocytes
12/09/2003US6660498 Malaria immunogenic composition
12/09/2003CA2171462C Compounds for the prevention and treatment of helminth infections
12/04/2003WO2003100045A1 Plant thymidine kinases and their use
12/04/2003WO2003099820A1 Pyrazolo-pyrimidine aniline compounds
12/04/2003WO2003099808A1 Substituted heterocyclic compounds and methods of use
12/04/2003WO2003099325A1 Methods for the in vitro culture of sporozoea sp. and user thereof
12/04/2003WO2003099302A1 A terpene-based composition of substances, a method for its preparation and a method for its dispersal into the atmosphere
12/04/2003WO2003087356A3 Helicokinin-receptor from insects
12/04/2003WO2003087322A3 Production of haematophagous organisms and parasites suitable for vaccine production
12/04/2003WO2003028736A3 Pharmaceutical preparations comprising alkyl phosphocholine compounds in liposomes which may be sterile-filtered or heat-sterilised
12/04/2003WO2003006996A3 Natural ligand of gpcr chemr23 and uses thereof
12/04/2003WO2002102310A3 Proteins associated with cell growth, differentiation, and death
12/04/2003WO2002074314A9 Therapeutical method involving subcutaneous administration of drugs containing cephalotaxine derivatives
12/04/2003WO2002068397A8 Diaminoquinazoline esters for use as dihydrofolate reductade inhibitors
12/04/2003WO2002049641A3 Anti-endoparasitic amidoacetonitrils
12/04/2003US20030225075 Novel pyrimidone derivatives
12/04/2003US20030225061 Protease inhibitors
12/04/2003US20030224008 Novel uses for anti-malarial therapeutic agents
12/04/2003US20030224007 A protective protein in the form of vaccine, containing a polypeptide from a pro-region of a cathepsin L protease obtained from excretory/secretory products of newly excysted juvenile stages of Fasciola hepatical
12/04/2003US20030224002 Administering to a patient having a disorder associtaed with an intracellular pathogen, a molecular conjugate of a photosensitizer and a targeting moiety, wherein the targeting moiety targets conjugate to the pathogen or infected cell
12/04/2003CA2486618A1 Methods for the in vitro culture of sporozoea sp. and uses thereof
12/04/2003CA2485166A1 Substituted pyrimidinone and pyridinone compounds
12/03/2003EP1366162A2 Putative proteins and nucleic acids encoding same
12/03/2003EP1366079A2 Nuclear hormone receptor ligand binding domain
12/03/2003EP1366065A1 Echinocandin derivatives, pharmaceutical compositions containing same and use thereof as drugs
12/03/2003EP1366064A1 Tumour targeting prodrugs activated by metallo matrixproteinases
12/03/2003EP1366028A1 Diaminoquinazoline esters for use as dihydrofolate reductase inhibitors
12/03/2003EP1075483B1 Hygromycin a derivatives
12/03/2003CN1129603C Heterocycles, its preparation, application and medicine contanining same
12/03/2003CN1129430C Formulations for controlling human lice
12/02/2003US6656971 Non-peptidic small organic compounds having an affinity for cyclophilin (CyP)-type immunophilins; inhibiting their peptidyl-prolyl isomerase activity; treating variety of medical conditions
12/02/2003US6656938 Inducing cytokine biosynthesis in animals, for the treatment of diseases, including viral and neoplastic diseases
1 ... 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 ... 218